[ad_1]
Reuters
Low Omicron efficacy behind delay of Pfizer COVID vaccine for teenagers underneath 5 – WSJ
Final week, the U.S. Meals and Drug Administration (FDA) stated it wanted extra information on the vaccine, delaying its determination for utilizing the vaccine in youngsters 6 months by means of 4 years of age for at the least two months. An early have a look at information confirmed the vaccine to be efficient towards the Delta variant throughout testing whereas that was the dominant pressure, however some vaccinated youngsters developed COVID-19 after Omicron emerged, the report stated, citing folks aware of the FDA’s determination. Nevertheless, for the reason that general COVID-19 instances have been low, the small variety of Omicron instances made the vaccine seem much less efficient in an early statistical evaluation, the report added.
[ad_2]
Source link